Novartis Investigative Site — Watertown, Massachusetts

Novartis Investigative Site is a clinical research site located in Watertown, Massachusetts, United States 02472.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 2 clinical trials.

Therapeutic areas: Relapsing Remitting Multiple Sclerosis, Patient Diagnosed With OCD and Resistant to SSRI Treatment, Failed SSRI Over 12 Weeks at Appropriate Doses.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 2 clinical trials on record. Their work covers Relapsing Remitting Multiple Sclerosis, Patient Diagnosed With OCD and Resistant to SSRI Treatment, Failed SSRI Over 12 Weeks at Appropriate Doses.

Is Novartis Investigative Site accredited by Crixeo Health?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.